DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer

Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT02393209 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC

NCT00238615 ·Status: TERMINATED ·Phase: PHASE2

Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00003562 ·Status: UNKNOWN ·Phase: PHASE2

Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer

NCT02157116 ·Status: TERMINATED ·Phase: PHASE2

A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients

NCT00201825 ·Status: COMPLETED ·Phase: PHASE2

Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer

NCT00005059 ·Status: COMPLETED ·Phase: PHASE2

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

NCT02839694 ·Status: WITHDRAWN ·Phase: PHASE1

A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

NCT00723957 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung Cancer

NCT00686985 ·Status: COMPLETED ·Phase: PHASE2

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

NCT00037817 ·Status: COMPLETED ·Phase: PHASE1

Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer

NCT00005868 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment

NCT01497041 ·Status: UNKNOWN ·Phase: PHASE2

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

NCT00432315 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

NCT00356122 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

NCT00003154 ·Status: COMPLETED ·Phase: PHASE2

Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer

NCT00145418 ·Status: TERMINATED ·Phase: PHASE2

Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00003762 ·Status: COMPLETED ·Phase: PHASE2

Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)

NCT00664105 ·Status: TERMINATED ·Phase: PHASE2

CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer

NCT03370159 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

NCT00047840 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00227565 ·Status: COMPLETED ·Phase: PHASE2

Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00075374 ·Status: COMPLETED ·Phase: PHASE2

Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00005646 ·Status: COMPLETED ·Phase: PHASE2

Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer

NCT00387660 ·Status: COMPLETED ·Phase: PHASE2

Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer

NCT00004265 ·Status: UNKNOWN ·Phase: PHASE2